MedDay raises $38.5 mln

MedDay has raised 34 million euros ($38.5 million ) in a Series B round of financing led by Edmond de Rothschild Investment Partners (EDRIP). Existing investors Sofinnova Partners and InnoBio participated as well as Bpifrance. MedDay, of Paris, is a biotechnology company focused on the treatment of nervous system disorders.

11 April 2016•6 mins read
Feature image
LinkedInXEmail
LinkedInXEmail